Literature DB >> 15090444

A molecular basis for nonsecretory myeloma.

Daniel Coriu1, Kristal Weaver, Maria Schell, Manfred Eulitz, Charles L Murphy, Deborah T Weiss, Alan Solomon.   

Abstract

The biosynthesis of aberrant immunoglobulin polypeptides by monoclonal plasma cells has been implicated in the pathogenesis of nonsecretory myeloma. Our studies of a patient with this disorder indeed have demonstrated the presence of abnormal kappa light chains that resulted from a frameshift mutation in nucleotides encoding the constant region of the molecule. As a consequence of a 2-base deletion in codon 187 and loss of the normal stop codon, this portion of the kappa chain was composed of 128 amino acids (rather than the expected 106), with a completely anomalous sequence after position 187 that included absence of the cysteines required for intrachain and interchain disulfide bonds. The unusual primary structure of this component was confirmed by mass spectrometric and amino acid sequence analyses of cytoplasmic protein extracts. Our studies provide the first evidence that human nonsecretory myeloma may result from an alteration in the light-chain constant region.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15090444     DOI: 10.1182/blood-2004-02-0477

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

1.  Comparable outcomes in nonsecretory and secretory multiple myeloma after autologous stem cell transplantation.

Authors:  Shaji Kumar; Waleska S Pérez; Mei-Jie Zhang; Karen Ballen; Asad Bashey; L Bik To; Christopher N Bredeson; Mitchell S Cairo; Gerald J Elfenbein; César O Freytes; Robert Peter Gale; John Gibson; Robert A Kyle; Martha Q Lacy; Hillard M Lazarus; Philip L McCarthy; Gustavo A Milone; Jan S Moreb; Santiago Pavlovsky; Donna E Reece; David H Vesole; Peter H Wiernik; Parameswaran Hari
Journal:  Biol Blood Marrow Transplant       Date:  2008-10       Impact factor: 5.742

2.  'Light-chain escape-multiple myeloma'-an escape phenomenon from plateau phase: report of the largest patient series using LC-monitoring.

Authors:  A Kühnemund; P Liebisch; K Bauchmüller; A zur Hausen; H Veelken; R Wäsch; M Engelhardt
Journal:  J Cancer Res Clin Oncol       Date:  2008-09-18       Impact factor: 4.553

3.  Cytogenetic Features and Clinical Outcomes of Patients With Non-secretory Multiple Myeloma in the Era of Novel Agent Induction Therapy.

Authors:  Bharat Nandakumar; Shaji K Kumar; Angela Dispenzieri; Francis K Buadi; David Dingli; Martha Q Lacy; Suzanne R Hayman; Prashant Kapoor; Nelson Leung; Amie Fonder; Miriam Hobbs; Yi Lisa Hwa; Eli Muchtar; Rahma Warsame; Taxiarchis V Kourelis; Stephen Russell; John A Lust; Yi Lin; Ronald S Go; Mustaqeem Siddiqui; Steven Zeldenrust; Robert A Kyle; Morie A Gertz; S Vincent Rajkumar; Wilson I Gonsalves
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2019-10-09

4.  Immunodiagnostic capabilities of anti-free immunoglobulin light chain monoclonal antibodies.

Authors:  Sandra Davern; Lian X Tang; Teresa K Williams; Sallie D Macy; Jonathan S Wall; Deborah T Weiss; Alan Solomon
Journal:  Am J Clin Pathol       Date:  2008-11       Impact factor: 2.493

5.  Oligo-secretory myeloma in a patient with ankylosing spondylitis.

Authors:  Eva Perez-Pampin; Joaquin Campos; Jorge Blanco; Manuel Perez-Encinas; Antonio Mera
Journal:  Rheumatol Int       Date:  2009-07-07       Impact factor: 2.631

6.  Non-secretory immunoglobulin E myeloma associated with immunoglobulin G monoclonal gammopathy of undetermined significance.

Authors:  Masako Yasuyama; Toshie Ogasawara; Kuniaki Otsuka; Motohiko Aiba; Kiyotaka Kawauchi
Journal:  Hematol Rep       Date:  2012-07-02

7.  The emergence of non-secretory multiple myeloma during the non-cytotoxic treatment of essential thrombocythemia: a case report.

Authors:  Danijela Leković; Mirjana Gotić; Olivera Mitrović; Milica Radojković; Jelena Bila; Marija Dencic-Fekete; Nada Kraguljac-Kurtović; Maja Peruničić-Jovanović; Vladan Cokić
Journal:  J Med Case Rep       Date:  2013-09-11

8.  Oligosecretory multiple myeloma: a case report.

Authors:  Ujjawal Khurana; Deepti Joshi; John A Santoshi; Tanya Sharma; Neelkamal Kapoor
Journal:  Blood Res       Date:  2016-03-25

Review 9.  Non-secretory multiple myeloma: from biology to clinical management.

Authors:  Megan Murray Dupuis; Sascha A Tuchman
Journal:  Onco Targets Ther       Date:  2016-12-15       Impact factor: 4.147

Review 10.  Non-Secretory Myeloma: Ready for a new Definition?

Authors:  Alessandro Corso; Silvia Mangiacavalli
Journal:  Mediterr J Hematol Infect Dis       Date:  2017-08-18       Impact factor: 2.576

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.